
Brandon McDonald Williams Periodic Transaction Report
Filed Jul 2, 2024 · House Clerk · 2 transactions
U.S. Representative · R · NY-22 · All trades by Brandon McDonald Williams
On July 2, 2024, Rep. Brandon McDonald Williams (R-NY-22) filed a periodic transaction report with the House Clerk disclosing 2 transactions (2 sales) dated Feb 1, 2023 through Jun 3, 2024.
The one asset reported, Visant Medical, Inc., is listed without a stock ticker. The filer coded it as "Stock (Not Publicly Traded)" on the House form.
Reported amount ranges sum to $2K–$30K. Congress reports trade sizes in ranges, not exact figures.
1 trade was reported more than 45 days after the trade date, outside the STOCK Act's 45-day window. The longest lag in this filing was 517 days.
Source document: House Clerk filing 20025387
Sample · the intelligence layer
Brandon McDonald Williams · Sold · Jun 3 · $1K–$15K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Brandon McDonald Williams
Get an email the moment Brandon McDonald Williams files the next one. Free, no card, no spam.
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Feb 1, 2023 | — | Visant Medical, Inc. Stock (Not Publicly Traded) | sell | — | $1K–$15K | 517d |
| Jun 3, 2024 | — | Visant Medical, Inc. Stock (Not Publicly Traded) | sell | — | $1K–$15K | 29d |
The line under an asset name is the asset type the filer selected on the House form, shown with the House Clerk's label for that code. It is the filer's coding, not a classification by Coldpine.
Other recent filings by Brandon McDonald Williams
- PTR filed Jul 10, 20241 trade
← All congressional filings, newest firstFiled Jul 2, 2024July 2024 archive
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →